|
| 37565972 | Frailty Status Modifies the Efficacy of ICD Therapy for Primary Prevention Among Patients With HF. | JACC Heart Fail | 2024 |
| 37950893 | Optimal Screening for Predicting and Preventing the Risk of Heart Failure Among Adults With Diabetes Without Atherosclerotic Cardiovascular Disease: A Pooled Cohort Analysis. | Circulation | 2024 |
| 37295180 | Risk Stratification in Patients Who Underwent Percutaneous Left Atrial Appendage Occlusion. | Am J Cardiol | 2023 |
| 37490295 | Racial and Ethnic Disparities and Facility-Level Variation in GLP-1 RA Prescription among US Veterans with CKD. | Clin J Am Soc Nephrol | 2023 |
| 38063209 | Prevalence and Predictors of Subclinical Cardiomyopathy in Patients With Type 2 Diabetes in a Health System. | J Diabetes Sci Technol | 2023 |
| 37158070 | Impact of Family History of Premature Coronary Artery Disease on Noninvasive Testing in Stable Chest Pain. | J Am Heart Assoc | 2023 |
| 37343814 | Conditional Survival After HeartMate 3 Implantation: An Analysis of the MOMENTUM 3 Trial. | J Card Fail | 2023 |
| 37115133 | Polypharmacy and Optimization of Guideline-Directed Medical Therapy in Heart Failure: The GUIDE-IT Trial. | JACC Heart Fail | 2023 |
| 37227388 | Effect of Canagliflozin on Heart Failure Hospitalization in Diabetes According to Baseline Heart Failure Risk. | JACC Heart Fail | 2023 |
| 34815060 | Phenomapping a Novel Classification System for Patients With Destination Therapy Left Ventricular Assist Devices. | Am J Cardiol | 2022 |
| 35616018 | Frailty Status Modifies the Efficacy of Exercise Training Among Patients With Chronic Heart Failure and Reduced Ejection Fraction: An Analysis From the HF-ACTION Trial. | Circulation | 2022 |
| 35476283 | Sex-based differences in patients undergoing transseptal transcatheter mitral valve replacement: Closing the sex disparity gap. | Catheter Cardiovasc Interv | 2022 |
| 35793094 | Machine Learning-Based Models Incorporating Social Determinants of Health vs Traditional Models for Predicting In-Hospital Mortality in Patients With Heart Failure. | JAMA Cardiol | 2022 |
| 35603908 | Mediators of ertugliflozin effects on heart failure and kidney outcomes among patients with type 2 diabetes mellitus. | Diabetes Obes Metab | 2022 |
| 35361446 | Frailty, Guideline-Directed Medical Therapy, and Outcomes in HFrEF: From the GUIDE-IT Trial. | JACC Heart Fail | 2022 |
| 35656988 | Validation of the WATCH-DM and TRS-HF<sub>DM</sub> Risk Scores to Predict the Risk of Incident Hospitalization for Heart Failure Among Adults With Type 2 Diabetes: A Multicohort Analysis. | J Am Heart Assoc | 2022 |
| 36280384 | Optimal cardiometabolic health and risk of heart failure in type 2 diabetes: an analysis from the Look AHEAD trial. | Eur J Heart Fail | 2022 |
| 35902163 | Supranormal Left Ventricular Ejection Fraction, Stroke Volume, and Cardiovascular Risk: Findings From Population-Based Cohort Studies. | JACC Heart Fail | 2022 |
| 36030198 | Development and validation of a model to predict cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke in patients with type 2 diabetes mellitus and established atherosclerotic cardiovascular disease. | Cardiovasc Diabetol | 2022 |
| 36378756 | Race, Social Determinants of Health, and Length of Stay Among Hospitalized Patients With Heart Failure: An Analysis From the Get With The Guidelines-Heart Failure Registry. | Circ Heart Fail | 2022 |
| 34860539 | Diabetes Status Modifies the Association Between Different Measures of Obesity and Heart Failure Risk Among Older Adults: A Pooled Analysis of Community-Based NHLBI Cohorts. | Circulation | 2022 |
| 35115086 | Transthyretin V142I Genetic Variant and Cardiac Remodeling, Injury, and Heart Failure Risk in Black Adults. | JACC Heart Fail | 2022 |
| 34730265 | Incorporation of natriuretic peptides with clinical risk scores to predict heart failure among individuals with dysglycaemia. | Eur J Heart Fail | 2022 |
| 33206129 | Association of Visit-to-Visit Variability in Kidney Function and Serum Electrolyte Indexes With Risk of Adverse Clinical Outcomes Among Patients With Heart Failure With Preserved Ejection Fraction. | JAMA Cardiol | 2021 |
| 33715025 | Development and validation of optimal phenomapping methods to estimate long-term atherosclerotic cardiovascular disease risk in patients with type 2 diabetes. | Diabetologia | 2021 |
| 33845593 | Development and Validation of Machine Learning-Based Race-Specific Models to Predict 10-Year Risk of Heart Failure: A Multicohort Analysis. | Circulation | 2021 |
| 34846526 | Longitudinal Trajectories and Factors Associated With US County-Level Cardiovascular Mortality, 1980 to 2014. | JAMA Netw Open | 2021 |
| 34649696 | Prevalence and Prognostic Implications of Diabetes With Cardiomyopathy in Community-Dwelling Adults. | J Am Coll Cardiol | 2021 |
| 34050919 | Prefrailty, impairment in physical function, and risk of incident heart failure among older adults. | J Am Geriatr Soc | 2021 |
| 34023263 | Deep-Learning Models for the Echocardiographic Assessment of Diastolic Dysfunction. | JACC Cardiovasc Imaging | 2021 |
| 34021682 | Omics, machine learning, and personalized medicine in heart failure with preserved ejection fraction: promising future or false hope? | Eur J Heart Fail | 2021 |
| 33317326 | Gender-Based Differences in Outcomes Among Resuscitated Patients With Out-of-Hospital Cardiac Arrest. | Circulation | 2021 |
| 33161766 | Association of Medicaid Expansion With Rates of Utilization of Cardiovascular Therapies Among Medicaid Beneficiaries Between 2011 and 2018. | Circ Cardiovasc Qual Outcomes | 2021 |
| 33212032 | Medicaid expansion and provision of prescription contraception to Medicaid beneficiaries. | Contraception | 2021 |
| 32540922 | Association of Long-term Change and Variability in Glycemia With Risk of Incident Heart Failure Among Patients With Type 2 Diabetes: A Secondary Analysis of the ACCORD Trial. | Diabetes Care | 2020 |
| 34327478 | County-level phenomapping to identify disparities in cardiovascular outcomes: An unsupervised clustering analysis: Short title: Unsupervised clustering of counties and risk of cardiovascular mortality. | Am J Prev Cardiol | 2020 |
| 31959648 | Response to Comment on Segar et al. Machine Learning to Predict the Risk of Incident Heart Failure Hospitalization Among Patients With Diabetes: The WATCH-DM Risk Score. Diabetes Care 2019;42:2298-2306. | Diabetes Care | 2020 |
| 31637815 | Phenomapping of patients with heart failure with preserved ejection fraction using machine learning-based unsupervised cluster analysis. | Eur J Heart Fail | 2020 |
| 33185651 | Association of Genetic West African Ancestry, Blood Pressure Response to Therapy, and Cardiovascular Risk Among Self-Reported Black Individuals in the Systolic Blood Pressure Reduction Intervention Trial (SPRINT). | JAMA Cardiol | 2020 |
| 30958721 | Generalizability and Implications of the H<sub>2</sub>FPEF Score in a Cohort of Patients With Heart Failure With Preserved Ejection Fraction. | Circulation | 2019 |
| 31519694 | Machine Learning to Predict the Risk of Incident Heart Failure Hospitalization Among Patients With Diabetes: The WATCH-DM Risk Score. | Diabetes Care | 2019 |
| 27374141 | Transmembrane protein 88 (TMEM88) promoter hypomethylation is associated with platinum resistance in ovarian cancer. | Gynecol Oncol | 2016 |
| 27199754 | Rifampin Regulation of Drug Transporters Gene Expression and the Association of MicroRNAs in Human Hepatocytes. | Front Pharmacol | 2016 |
| 25968989 | Age-Related Changes in MicroRNA Expression and Pharmacogenes in Human Liver. | Clin Pharmacol Ther | 2015 |
| 26357319 | MMBIRFinder: A Tool to Detect Microhomology-Mediated Break-Induced Replication. | IEEE/ACM Trans Comput Biol Bioinform | 2015 |
| 24564718 | Spectral probabilities of top-down tandem mass spectra. | BMC Genomics | 2014 |
| 25035395 | Epigenetic targeting of ovarian cancer stem cells. | Cancer Res | 2014 |
| 25470663 | TGF-β induces global changes in DNA methylation during the epithelial-to-mesenchymal transition in ovarian cancer cells. | Epigenetics | 2014 |